Fingerprint
Dive into the research topics where Tavs Qvist is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Elexacaftor/tezacaftor/ivacaftor is safe and effectively reduces sino-nasal symptoms in people with cystic fibrosis post lung transplantation
Mathiesen, I. H. M., Rönsholt, F. F., Aanæs, K., Bille, J., von Buchwald, C., Jensen-Fangel, S., Qvist, T., Katzenstein, T. L., Bendstrup, E., Perch, M. & Jeppesen, M., Jun 2026, In: Respiratory medicine. 257, 108807.Research output: Contribution to journal › Journal article › Research › peer-review
-
Lineages and adapted phenotypes of Pseudomonas aeruginosa persist during elexacaftor/tezacaftor/ivacaftor therapy
Bendixen, M. P., Irazoki, O., Marvig, R. L., Skov, M., Qvist, T., Molin, S. & Johansen, H. K., 2026, (E-pub ahead of print) In: Clinical Microbiology and Infection .Research output: Contribution to journal › Letter › peer-review
-
Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23
Leo-Hansen, C., Nielsen, B. U., Bryrup, T., Jeppesen, M., Kolpen, M., Jensen, P. Ø., Høiby, N., Pressler, T., Johansen, H. K., Faurholt-Jepsen, D., Olsen, M. F., Jensen, C. B., Qvist, T. & Danish Study Group on Mycobacterial Infections in Cystic Fibrosis, Mar 2026, In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 25, 2, p. 240-247 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis
Bader-Larsen, K., Nielsen, B. U., Henriksen, E., Bryrup, T., Leo-Hansen, C., Mathiesen, I. H. M., Faurholt-Jepsen, D., Qvist, T., Oturai, P., Langdahl, B., Jeppesen, M., Olsen, H. V., Pressler, T., Skov, M., Olsen, M. F. & Transform CF Study Group, Nov 2025, In: Clinical nutrition (Edinburgh, Scotland). 54, p. 132-139 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Change in pulmonary pathogens three years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort
Bendixen, M. P., Jeppesen, M., Irazoki, O., Jensen, C. B., Wang, M., Petersen, J., Katzenstein, T. L., Pressler, T., Skov, M., Olesen, H. V., Jensen-Fangel, S., Qvist, T., Johansen, H. K. & TransformCF study group, Dec 2025, In: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 31, 12, p. 2011-2017 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
5 Citations (Scopus)